SQUAMOUS CELL ESOPHAGEAL CARCINOMA IN A YOUNGER FEMALE PATIENT: A CASE REPORT
Sažetak
Karcinom jednjaka je šesti vodeći uzrok smrti od malignih bolesti. Dva najčešća tipa karcinoma jednjaka su: skvamocelularni karcinom i adenokarcinom jednjaka. Faktori rizika za nastanak ovih karcinoma su starosni uzrast od 60 do 70 godina, ahalazija, pušenje, konzumiranje alkohola, pripadnost crnoj rasi i dr. Glavni simptomi karcinoma jednjaka su otežano gutanje čvrste, a potom i tečne hrane, gubitak na telesnoj težini, bolovi prilikom gutanja, kaheksija, kašalj ili promuklost. Dijagnostika se vrši primenom radiološke kontrastne pasaže jednjaka, proksimalne endoskopije, kompjuterizovane tomografije i endoskopskog ultrazvuka. Prognoza je loša sa petogodišnjim preživljavanjem od 15% do 25%. Rano otkrivanje i citostatsko i hirurško lečenje ključni su za uspešnu terapiju ove bolesti. Prikazujemo klinički slučaj neuobičajene pojave ezofagealnog karcinoma kod bolesnice mlađe životne dobi. Prikazani su izazovi dijagnostičkog postupka i primenjena terapija.
Reference
American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society; 2016.
Ashktorab H, Nouri Z, Nouraie M, Razjouyan H, Lee EE, Dowlati E et al. Esophageal carcinoma in African Americans: a five-decade experience. Dig Dis Sci 2011;56(12):3577-82. [CrossRef] [PubMed]
Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P et al. Trends in oesophageal cancer inci-dence and mortality in Europe. Int J Cancer 2008; 122:1118-29. [CrossRef] [PubMed]
Dawsey SP, Tonui S, Parker R, Filzwater JW, Dawsey SM, White RE et al. Esophageal Cancer in Young People: A Case Series of 109 Cases and Review of the Literature. PLoS ONE 2010;5(11):e14080. [CrossRef] [PubMed]
Filipović S. Maligni tumori ezofagusa. In: Filipović S, editor. Osnovi kliničke onkologije. Niš: Prosveta; 2009. p. 143.
Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165(12):1424-33. [CrossRef] [PubMed]
Ilić S. Tumori jednjaka. In: Interna medicina. Niš: Prosveta; 2004. p. 182-83.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90. [CrossRef] [PubMed]
Menges M. Ösophaguskarzinom – Diagnostik. Praxis 2012;93:2047-50. [CrossRef] [PubMed]
Oezcelik A, Ayazi S, DeMeester SR, Zehetner J, Abate E, Dunn J et al. Adenocarcinoma of the esophagus in the young. J Gastrointest Surg 2013;17:1032-5. [CrossRef] [PubMed]
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca - A Cancer Journal for Clinicians 2005;55:74-108. [CrossRef] [PubMed]
Pickens A, Orringer MB. Geographical distribution and racial disparty in esophageal cancer. Ann Thorac Surg 2003;76:1367-9. [CrossRef] [PubMed]
Saddoughi SA, Taswell J, Spears GM, Harmsen WS, Allen MS, Blackmon SH et al. Patients younger than 45 years of age have superior 5-year survival in advanced esophageal cancer. Shanghai Chest 2019; 3:42. [CrossRef]
Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing icidence trends in the United States: 1999 trough 2008. CA Cancer J Clin 2012;62:118-28. [CrossRef] [PubMed]
Vallböhmer D, Hölscher AH, Brabender J, Prenzel K, Gutschow C, Schröder W et al. Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a differ-ence? Dis Esophagus 2008;21:596-600. [CrossRef] [PubMed]
Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am 2012;92(5):1077-87. [CrossRef] [PubMed]